Precision BioSciences

Cindy Atwell, Senior Vice President, Business Development

Durham, NC

(NASDAQ: DTIL)

Virtual Presentation

Precision BioSciences is a clinical-stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform designed with therapeutic safety, delivery, and control in mind. Using ARCUS, Precision is developing allogeneic CAR T and in vivo gene correction therapies for cancer and rare diseases.

www.precisionbiosciences.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions